PDF herunterladen
Bae, Yoon-Soo Cindy et al.: 2023 Procedural Dermatology: Postresidency and Fellowship Compendium, Volume 2 DOI: 10.1055/b-0043-196760

22 Kybella/Deoxycholic Acid/Off-Label Uses

Weitere Informationen

Buch

Herausgeber: Bae, Yoon-Soo Cindy; Ciocon, David H.

Autoren: Bae, Gee Young; Bernstein, Leonard J.; Boker, Andreas; Borash, Jordan; Bosley, Rawn; Brauer, Jeremy A.; Brown, Wilfred; Callaghan, Daniel; Chesnut, Cameron; Christman, Mitalee P.; Criscito, Maressa C.; Ebersole, Trina G.; Emer, Jason; Fabi, Sabrina Guillen; Fazzalari, Amanda; Friedman, Adam; Friedmann, Daniel P.; Geronemus, Roy G.; Goldberg, David J.; Gordon, Samantha; Graber, Emmy M.; Hazan, Ezra; Kent, Rhett A.; Khorasani, Hooman; Lederhandler, Margo H.; Lee, Austin; Li, Monica K.; Lin, Richard L.; Lipp, Michael B.; MacGregor, Jennifer L.; Mann, Margaret; Mehrabi, Joseph N.; Mishra, Vineet; Moak, Teri N.; Morton, Laurel M.; Murgia, Robert D.; Murphy, Emily C.; Paul, Benjamin Curman; Robinson, Deanne Mraz; Rokhsar, Cameron; Saedi, Nazanin; Scott, Jeffrey F.; Shridharani, Sachin M.; Soon, Seaver L.; Steele, Robert Blake; Steuer, Alexa B.; Tamashunas, Nina Lucia; Tan, Andrea; Tisch, Grace M.; Wang, Jordan V.; Weiss, Robert; Yeh, Lindsey; Zumwalt, Michael

Titel: Procedural Dermatology: Postresidency and Fellowship Compendium, Volume 2

Print ISBN: 9783132424074; Online ISBN: 9783132437142; Buch-DOI: 10.1055/b000000254

1. Edition © 2023. Thieme. All rights reserved.
Georg Thieme Verlag KG, Stuttgart,

Fachgebiete: Dermatologie;Allergologie

Thieme Clinical Collections (English Language)



 
Sachin M. Shridharani, Teri N. Moak, Trina G. Ebersole, and Grace M. Tisch

Summary

Fat reduction for facial and body contouring continues to be one of the most sought-after aesthetic procedures. There continues to be a keen interest in permanent reduction of adipocyte deposition by less invasive methods. The introduction of injectable deoxycholic acid has had a profound impact on aesthetic facial and body contouring by offering both clinicians and patients an FDA-approved option to reduce the appearance of unwanted fat. This chapter serves as an overview to assist the clinician interested in incorporating this treatment into their practice and a top line summary of alternatives.

Schlüsselwörter

Kybella - deoxycholic acid - DCA - kythera - fat-reduction - aesthetic facial contouring - liposuction
 
  • 1 Chia CT, Neinstein RM, Theodorou SJ. Evidence-based medicine: liposuction.. Plast Reconstr Surg 2017; 139 (1) 267e-274e PubMed (PMID: 28027260)
    Google Scholar
  • 2 Shridharani SM, Broyles JM, Matarasso A. Liposuction devices: technology update.. Med Devices (Auckl) 2014; 7: 241-251 PubMed (PMID: 25093000)
    Google Scholar
  • 3 Bellini E, Grieco MP, Raposio E. A journey through liposuction and liposculture: Review.. Ann Med Surg (Lond) 2017; 24: 53-60 PubMed (PMID: 29158895)
    Google Scholar
  • 5 Apfelberg D. Laser-assisted liposuction may benefit surgeons, patients.. Clin Laser Mon 1992; 10 (12) 193-194 PubMed (PMID: 10148278)
    Google Scholar
  • 6 Lee JC, Daniels MA, Roth MZ. Mesotherapy, microneedling, and chemical peels.. Clin Plast Surg 2016; 43 (3) 583-595 PubMed (PMID: 27363773)
    Google Scholar
  • 7 FDA. Prescribing information. KYBELLA injection. Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206333Orig1s000lbl.pdf. Accessed November 16, 2017
  • 8 KYTHERA Biopharmaceuticals, Inc. KYTHERA Biopharmaceuticals Announces Health Canada Authorization of BELKYRA(TM), a Submental Contouring Injectable Drug(i). Available from: http://www.kythera.com/kythera-biopharmaceuticals-announces-health-canada-authorization-of-belkyra-a-submental-contouring-injectable-drug/. Accessed
  • 9 FDA. FDA Approves Treatment for Fat below the Chin. Available from: http://wayback.archive-it.org/7993/20171115021407/https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm444978.htm
  • 10 Cardis MA, DeKlotz CMC. Intralesional deoxycholic acid treatment for fibrofatty residua of involuted infantile hemangiomas: a novel therapeutic approach.. JAMA Dermatol 2018; 154 (6) 735-737 PubMed (PMID: 29801031)
    Google Scholar
  • 11 Dubin DP, Farberg AS, Lin MJ, Khorasani H. Intralesional deoxycholic acid as neoadjuvant treatment of a large lipoma.. Dermatol Surg 2020; 46 (5) 715-717 PubMed (PMID: 31318828)
    Google Scholar
  • 12 Fredriksen JH, Rosenqvist E, Wedege E et al. Production, characterization and control of MenB-vaccine “Folkehelsa”: an outer membrane vesicle vaccine against group B meningococcal disease.. NIPH Ann 1991; 14 (2) 67-79, discussion 79–80 PubMed (PMID: 1812438)
    Google Scholar
  • 13 Yang J, Li ZH, Zhou JJ et al. Preparation and antitumor effects of nanovaccines with MAGE-3 peptides in transplanted gastric cancer in mice.. Chin J Cancer 2010; 29 (4) 359-364 PubMed (PMID: 20346208)
    Google Scholar
  • 14 Yuba E, Sakaguchi N, Kanda Y, Miyazaki M, Koiwai K. pH-responsive micelle-based cytoplasmic delivery system for induction of cellular immunity.. Vaccines (Basel) 2017; 5 (4) E41 PubMed (PMID: 29113042)
    Google Scholar
  • 15 American Society for Aesthetic Plastic Surgery (ASAPS). Aesthetic Plastic Surgery National Data Bank Statistics. Available from: https://www.surgery.org/sites/default/files/Aesthetic-Society_Stats2019Book_FINAL.pdf Accessed June 25, 2020
  • 2 Center for Drug Evaluation and Research. Kybella Medical Review. Application number: 206333Orig1s000. Available from https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/206333Orig1s000MedR.pdf. Accessed June 25, 2020
  • 17 Shridharani SM, Behr KL. ATX-101 (deoxycholic acid injection) treatment in men: insights from our clinical experience.. Dermatol Surg 2017; 43 (Suppl. Suppl 2) S225-S230 PubMed (PMID: 28902021)
    Google Scholar
  • 18 Ascher B, Hoffmann K, Walker P, Lippert S, Wollina U, Havlickova B. Efficacy, patient-reported outcomes and safety profile of ATX-101 (deoxycholic acid), an injectable drug for the reduction of unwanted submental fat: results from a phase III, randomized, placebo-controlled study.. J Eur Acad Dermatol Venereol 2014; 28 (12) 1707-1715 PubMed (PMID: 24605812)
    Google Scholar
  • 19 Humphrey S, Sykes J, Kantor J et al. ATX-101 for reduction of submental fat: a phase III randomized controlled trial.. J Am Acad Dermatol 2016; 75 (4) 788-797.e7 PubMed (PMID: 27430612)
    Google Scholar
  • 20 Jones DH, Carruthers J, Joseph JH et al. REFINE-1, a multicenter, randomized, double-blind, placebo-controlled, phase 3 trial with ATX-101, an injectable drug for submental fat reduction.. Dermatol Surg 2016; 42 (1) 38-49 PubMed (PMID: 26673433)
    Google Scholar
  • 21 Rzany B, Griffiths T, Walker P, Lippert S, McDiarmid J, Havlickova B. Reduction of unwanted submental fat with ATX-101 (deoxycholic acid), an adipocytolytic injectable treatment: results from a phase III, randomized, placebo-controlled study.. Br J Dermatol 2014; 170 (2) 445-453 PubMed (PMID: 24147933)
    Google Scholar
  • 22 Humphrey S, Dayan SH, Shridharani SM, et al. Personal and Social Impacts of Submental Fat in the US Population. Presented at Fall Clinical Dermatology Conference on Las Vegas, NV, October 20–23, 2016
  • 23 Humphrey S, Dayan SH, Shridharani SM, et al. Social Perceptions before and after Treatment with ATX-101 (Deoxycholic Acid Injection) for Reduction of Submental Fat. Presented at the American Academy of Dermatology Annual Meeting on Orlando, FL, March 3–7, 2017
  • 24 Jagdeo J, Keaney T, Narurkar V, Kolodziejczyk J, Gallagher CJ. Facial treatment preferences among aesthetically oriented men.. Dermatol Surg 2016; 42 (10) 1155-1163 PubMed (PMID: 27661428)
    Google Scholar
  • 25 Raveendran SS, Anthony DJ, Ion L. An anatomic basis for volumetric evaluation of the neck.. Aesthet Surg J 2012; 32 (6) 685-691 PubMed (PMID: 22859541)
    Google Scholar
  • 12 Hatef DA, Koshy JC, Sandoval SE, Echo AP, Izaddoost SA, Hollier LH. The submental fat compartment of the neck.. Semin Plast Surg 2009; 23 (4) 288-291 PubMed (PMID: 21037865)
    Google Scholar
  • 13 Shridharani SM. Early experience in 100 consecutive patients with injection adipocytolysis for neck contouring with ATX-101 (deoxycholic acid).. Dermatol Surg 2017; 43 (7) 950-958 PubMed (PMID: 28448317)
    Google Scholar
  • 14 Beer K, Donofrio L, Gross TM, Beddingfield FC III. Clinically Meaningful Reduction in Submental Fat during and after Treatment with ATX-101 in the US/CAN Phase 3 Trials, REFINE-1 and REFINE-2. Presented at American Academy of Dermatology Annual Meeting on San Francisco, CA, March 20–24, 2015
  • 29 Shridharani SM, Chandawarkar AA. Novel expanded safe zone for reduction of submental fullness with ATX-101 injection.. Plast Reconstr Surg 2019; 144 (6) 995e-1001e PubMed (PMID: 31764639)
    Google Scholar
  • 30 Shridharani SM. Injection of an adipocytolytic agent for reduction of excess periaxillary fat.. Aesthet Surg J 2019; 39 (12) NP495-NP503 PubMed (PMID: 30869117)
    Google Scholar
  • 31 Sykes JM, Allak A, Klink B. Future applications of deoxycholic acid in body contouring.. J Drugs Dermatol 2017; 16 (1) 43-46 PubMed (PMID: 28095531)
    Google Scholar
  • 32 Verma KD, Somenek MT. Deoxycholic acid injection as an effective treatment for reduction of posterior upper torso brassiere strap adiposity.. Plast Reconstr Surg 2018; 141 (1) 200e-202e PubMed (PMID: 28938373)
    Google Scholar
  • 33 Jegasothy SM. Deoxycholic acid injections for bra-line lipolysis.. Dermatol Surg 2018; 44 (5) 757-760 PubMed (PMID: 29016540)
    Google Scholar
  • 34 Asaadi M. Etiology and treatment of congenital festoons.. Aesthetic Plast Surg 2018; 42 (4) 1024-1032 PubMed (PMID: 29671023)
    Google Scholar
  • 35 Newberry CI, Mccrary H, Thomas JR, Cerrati EW. updated management of malar edema, mounds, and festoons: a systematic review.. Aesthet Surg J 2020; 40 (3) 246-258 PubMed (PMID: 31051517)
    Google Scholar
  • 36 Ascha M, Swanson MA, Massie JP et al. Nonsurgical management of facial masculinization and feminization.. Aesthet Surg J 2019; 39 (5) NP123-NP137 PubMed (PMID: 30383180)
    Google Scholar
  • 37 Dover JS, Shridharani SM, Bloom JD, Somogyi C, Gallagher CJ. Reduction of submental fat continues beyond 28 days after ATX-101 treatment: results from a post hoc analysis.. Dermatol Surg 2018; 44 (11) 1477-1479 PubMed (PMID: 29419542)
    Google Scholar
  • 38 Baumann L, Shridharani SM, Humphrey S, Gallagher CJ. Personal (self) perceptions of submental fat among adults in the United States.. Dermatol Surg 2019; 45 (1) 124-130 PubMed (PMID: 30234657)
    Google Scholar
  • 39 Shridharani SM, Chandawarkar AA. Novel expanded safe zone for reduction of submental fullness with ATX-101 injection.. Plast Reconstr Surg 2019; 144 (6) 995e-1001e PubMed (PMID: 31764639)
    Google Scholar
  • 40 Jones DH, Carruthers J, Joseph JH et al. REFINE-1, a multicenter, randomized, double-blind, placebo-controlled, phase 3 trial with ATX-101, an injectable drug for submental fat reduction.. Dermatol Surg 2016; 42 (1) 38-49 PubMed (PMID: 26673433)
    Google Scholar
  • 41 Yang H-M, Kim HJ, Park HW et al. Revisiting the topographic anatomy of the marginal mandibular branch of facial nerve relating to the surgical approach.. Aesthet Surg J 2016; 36 (9) 977-982 PubMed (PMID: 27025245)
    Google Scholar
  • 42 Kythera Biopharmaceuticals, Inc. KYBELLA (deoxycholic acid) injection [prescribing information]. Available from: https://www.allergan.com/assets/pdf/kybella_pi. Accessed July 8, 2020
  • 43 Sung CT, Lee A, Choi F, Juhasz M, Mesinkovska NA. Non-submental applications of injectable deoxycholic acid: a systematic review.. J Drugs Dermatol 2019; 18 (7) 675-680 PubMed (PMID: 31334926)
    Google Scholar
  • 44 Shridharani SM. Improvement in jowl fat following ATX-101 treatment: results from a single-site study.. Plast Reconstr Surg 2020; 145 (4) 929-935 PubMed (PMID: 32221205)
    Google Scholar
  • 45 Shridharani SM. Injection of an adipocytolytic agent for reduction of excess periaxillary fat.. Aesthet Surg J 2019; 39 (12) NP495-NP503 PubMed (PMID: 30869117)
    Google Scholar
  • 46 Rzany B, Griffiths T, Walker P, Lippert S, McDiarmid J, Havlickova B. Reduction of unwanted submental fat with ATX-101 (deoxycholic acid), an adipocytolytic injectable treatment: results from a phase III, randomized, placebo-controlled study.. Br J Dermatol 2014; 170 (2) 445-453 PubMed (PMID: 24147933)
    Google Scholar
  • 47 Ascher B, Hoffmann K, Walker P, Lippert S, Wollina U, Havlickova B. Efficacy, patient-reported outcomes and safety profile of ATX-101 (deoxycholic acid), an injectable drug for the reduction of unwanted submental fat: results from a phase III, randomized, placebo-controlled study.. J Eur Acad Dermatol Venereol 2014; 28 (12) 1707-1715 PubMed (PMID: 24605812)
    Google Scholar
  • 48 McDiarmid J, Ruiz JB, Lee D, Lippert S, Hartisch C, Havlickova B. Results from a pooled analysis of two European, randomized, placebo-controlled, phase 3 studies of ATX-101 for the pharmacologic reduction of excess submental fat.. Aesthetic Plast Surg 2014; 38 (5) 849-860 PubMed (PMID: 24984785)
    Google Scholar
  • 49 Dayan S, Jones DH, Carruthers J et al. A pooled analysis of the safety and efficacy results of the multicenter, double-blind, randomized, placebo-controlled phase 3 REFINE-1 and REFINE-2 trials of ATX-101, a submental contouring injectable drug for the reduction of submental fat.. Plast Reconstr Surg 2014; 134: 123 (PMID: NOT_FOUND)
    Google Scholar
  • 50 Shridharani SM, Behr KL. ATX-101 (deoxycholic acid injection) treatment in men: insights from our clinical experience.. Dermatol Surg 2017; 43 (Suppl. Suppl 2) S225-S230 PubMed (PMID: 28902021)
    Google Scholar
  • 51 Grady B, Porphirio F, Rokhsar C. Submental alopecia at deoxycholic acid injection site.. Dermatol Surg 2017; 43 (8) 1105-1108 PubMed (PMID: 28291068)
    Google Scholar
  • 52 Shridharani SM. Early experience in 100 consecutive patients with injection adipocytolysis for neck contouring with ATX-101 (deoxycholic acid).. Dermatol Surg 2017; 43 (7) 950-958 PubMed (PMID: 28448317)
    Google Scholar